1. Growth Inhibitory Effects of IFN-βon Human Liver Cancer Cells In Vitroand In Vivo.
- Author
-
Sachiko Ogasawara, Hirohisa Yano, Seiya Momosaki, Jun Akiba, Naoyo Nishida, Sakiko Kojiro, Fukuko Moriya, Hironori Ishizaki, Keitaro Kuratomi, and Masamichi Kojiro
- Subjects
LIVER cancer ,FLUOROURACIL ,FLUOROPYRIMIDINES ,TUMORS - Abstract
We investigated the effects of interferon-β(IFN-β) on the growth of human liver cancer cells. The effects of IFN-βwith or without 5-fluorouracil (5-FU) on the proliferation of 13 liver cancer cell lines were investigated in vitro. Chronologic change in IFN-αreceptor 2 (IFNAR-2) expression was monitored in hepatocellular carcinoma (HCC) cells (HAK-1B) cultured with IFN-β. After HAK-1B cells were transplanted into nude mice, various doses of IFN-βwere administered, and the tumor volume, weight, histology, tumor blood vessel, and angiogenesis factor expression were examined. IFN-βinhibited the growth of 11 cell lines with apoptosis in a dose-dependent and time-dependent manner. With IFN-β, IFNAR-2 expression in HAK-1B cells was significantly downregulated from 6 to 12 h. IFN-βinduced a dose-dependent decrease in tumor volume and weight and a significant increase of apoptosis in the tumor. Both basic fibroblast growth factor (bFGF) and blood vessel number in the tumor decreased only in mice receiving the lowest dose (1000 IU) of IFN-β. IFN-βwith 10 μM of 5-FU frequently induced synergistic antiproliferative effects. IFN-βwith or without 5-FU induces strong antitumor effects in HCC cells, and we conclude that IFN-βis useful for the prevention and treatment of HCC. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF